NEW! Investment Companies Centre

Alizyme (AZM)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE Small Cap

Market Cap

£21.84m

Change Today

Price Down-0.62p ()

Share Price

9.88p

Major Interest in Shares

RNS Number : 2362D
Alizyme PLC
11 September 2008
 
For Immediate Release
11 September 2008
 
ALIZYME PLC
 
 
TR – 1:
NOTIFICATION OF MAJOR INTERESTS IN SHARES
 
 
1.         Identity of the issuer or the underlying issuer of existing shares to which voting rights 
   are attached:
 
  Alizyme plc
 
2.         Reason for the notification:
 
 An acquisition or disposal of voting rights
 
 
3.         Full name of person(s) subject to the notification obligation:
 
  Barclays PLC
 
4.         Full name of shareholder(s) (if different from 3.)
 
 
5.         Date of the transaction and date on which the threshold is crossed or reached:
 
            8 September 2008
 
6.         Date on which issuer notified:
 
            10 September 2008
 
7.         Threshold(s) that is/are crossed or reached:
 
            5%
 
8.         Notified details:
 
A: Voting rights attached to shares
 
Class/type of shares
if possible using the ISIN CODE
Situation previous to the Triggering transaction
Resulting situation after the triggering transaction
Number of Shares
Number of Voting Rights
Number of shares
Number of voting rights
% of voting rights
 
Direct
Indirect
Direct
Indirect
Ordinary Shares
GB0000374289
11,060,878
11,060,878
Not Reportable
Not Reportable
Not Reportable
Not Reportable
Not Reportable
 


 

 
B: Financial Instruments
 
Resulting situation after the triggering transaction
Type of financial instrument
Expiration date
Exercise/ Conversion
Period/Date
Number of voting rights that may be acquired if the instrument is exercised/ converted.
% of voting rights
 
n/a
 
n/a
 
n/a
 
n/a
 
n/a
 
Total (A+B)
 
Number of voting rights
% of voting rights
Not Reportable
Not Reportable
 
9.       Chain of controlled undertakings through which the voting rights and/or the financial 
 instruments are effectively held, if applicable
 
Proxy Voting:
 
10.      Name of the proxy holder:
 
  n/a
 
11.       Number of voting rights proxy holder will cease to hold:
 
  n/a
 
12.       Date on which proxy holder will cease to hold voting rights:
 
  n/a
 
13.       Additional information
 
  n/a
 
14.       Contact name:
 
            Nick Blech, Company Secretary
 
15.       Contact telephone number:
 
            + 44 (0) 1223 896000
 
For further information, please contact:
 
Nick Blech, Company Secretary
 
ALIZYME plc
Tel No: + 44 (0) 1223 896000
 
Further information on Alizyme can be found on the Company’s website:
 
 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLFFLFFVKBEBBF

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).